NCT07179263

Brief Summary

This clinical study employs a single-center, split-face, randomized, and on-site controlled design to compare two methods for inducing skin redness (50% Glycolic Acid application and tape stripping) on the face and forearm in a minimum of 40 healthy female subjects. The study involves instrumental measurements (erythema index and a\* value), photographic analysis, and expert clinical grading at multiple time points (baseline, 10min, 30min, 1h, 2h, and 4h after induction) to evaluate and compare the efficacy and response profiles of both irritation models.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 22, 2023

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2023

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 11, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 17, 2025

Completed
Last Updated

September 17, 2025

Status Verified

September 1, 2025

Enrollment Period

7 days

First QC Date

September 11, 2025

Last Update Submit

September 11, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in erythema index by Mexameter® MX 18 (

    From baseline to 4-hour after inducing

  • Change in a* value by Chromameter CM26dG

    The a\*value is a parameter in the CIELAB color space (also known as Lab) that quantifies a color's position along the red-green axis .

    From baseline to 4-hour after inducing

  • Facial Erythema Severity via VISIA-CRP Imaging

    From baseline to 4-hour after inducing

  • Forearm Erythema Intensity via Cross-Polarized Light Imaging

    From baseline to 4-hour inducing

Study Arms (4)

Facial Test Arm

OTHER
Other: 50% glycolic acidOther: Tape Stripping

Facial Control Arm

NO INTERVENTION

Arm Test arm

OTHER
Other: Tape Stripping

Arm control arm

NO INTERVENTION

Interventions

Subjects use 3 drops about 0.2g of 50% Glycolic Acid product on half face under instruction, then wait for 3 minutes and wash face by tap water. Wait for 10 minutes before measuring.

Facial Test Arm

Technician use the D100 to paste on the center of the test area and make it fit the skin more completely and evenly by pump fully cover the D100 patch for 10 seconds. Stripping on each test area until the skin change into redness. The number of stripping will be recorded.

Arm Test armFacial Test Arm

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Chinese female whose age range from 18 to 60 years old;
  • Be in general good health and good mental state;
  • Have no any broken, scars, birthmarks and other imperfections on the test area;
  • Redness/erythema ≥ grade 2 after modelling inducing (to ensure the consistency of the baseline for comparison);
  • Haven't applied Alpha hydroxyl acid in the past 3 months;
  • Not currently be participating in any other study involving the test area (Face and Forearm);
  • Not have participated in any other study involving the test area in the past one month;
  • Be willing to read, understand and able to sign the Informed Consent Form and Photo Release From;
  • Be willing to comply with all study protocol requirements.

You may not qualify if:

  • Intending to get pregnant, be pregnant, be lactating, be within 6 months of delivery or be unwilling to take necessary precautions to avoid a pregnancy;
  • Having used antihistamine drugs in the past 1 week or immunosuppressants in the past 1 month;
  • Take anti-allergic drug/injections in the past 1 month;
  • Presently have allergies, allergic dermatitis or skin disease;
  • Have sensitivity or even allergy to topical products, ingredients or fragranced products;
  • Have history of allergies;
  • Have history of suffering from skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.);
  • Have used any anti-inflammatory treatment on the test area within 2 months prior to this study starting date;
  • Has a chronic medical condition that may interfere with testing (e.g., asthma, insulin-dependent diabetes, lupus, rheumatoid arthritis or other immune/auto-immune diseases);
  • Have used any scrubs or peeling product (regardless of method) or self-tanning products or oil control products in the past 3 days;
  • Have received cosmetic medical procedures on the face (such as injectable anti-wrinkle products, cosmetic surgery, tattoo removal, home light facial procedures or home use medical devices, etc.) in the past 1 month;
  • Have excessive sun exposure or ultraviolet light in the past 1 month;
  • Have applied ortho-hydroxybenzoic acid, hydroquinone in the past 3 months; or used prescriptions (such as antibiotic, retinoids, alpha hydroxyl acid and steroid), oral contraceptives (such as Diane 35®,Jasmine®, Holgyeme®,Syndi 35®,Regulon®);
  • Avoid providing emergency contact;
  • Subjects that are not compliant to the selection criteria or not proper for participation as determined by Principal Investigator;
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai China-norm Quality Technical Service Co., Ltd.

Shanghai, Shanghai Municipality, 200072, China

Location

MeSH Terms

Conditions

Erythema

Interventions

glycolic acid

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesSkin ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 17, 2025

Study Start

December 22, 2023

Primary Completion

December 29, 2023

Study Completion

December 29, 2023

Last Updated

September 17, 2025

Record last verified: 2025-09

Locations